Redhill Biopharma Ltd. - American Depositary Shares (NQ:RDHL)

0.5000 +0.0200 (+4.17%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Redhill Biopharma Ltd. - American Depositary Shares

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

RedHill’s Movantik Added To Medicare Formulary

December 01, 2021

RedHill Biopharma's Movantik® Added as Preferred and Unrestricted Brand To Major National Medicare Formulary Serving Millions of Americans Movantik® approved for inclusion as preferred and unrestricted...

From RedHill Biopharma Ltd

Via AccessWire

Topics Intellectual Property Regulatory Compliance

The Daily Biotech Pulse: Cumberland Jumps On FDA Nod, Regeneron Says Antibody Treatment May Be Less Effective Against Omicron, ImmunoGen Readout ↗

November 30, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Cumberland Gets FDA Approval For IV-Delivered Ibuprofen For Use In Pre-...

Via Benzinga

RedHill Reports 3Q/2021 Financial Results

November 30, 2021

RedHill Biopharma Reports Operational Highlights and Third Quarter 2021 Financial Results RedHill Accelerates its Two Advanced COVID-19 Pill Clinical Programs in Light of their Potential Against...

From RedHill Biopharma Ltd

Via AccessWire

Topics Intellectual Property Regulatory Compliance

Earnings Scheduled For November 30, 2021 ↗

November 30, 2021

Companies Reporting Before The Bell • Hello Gr (NASDAQ:MOMO) is estimated to report quarterly earnings at $0.31 per share on revenue of $573.63 million. • UP...

Via Benzinga

Earnings Preview For Redhill Biopharma ↗

November 29, 2021

Redhill Biopharma (NASDAQ:RDHL) is set to give its latest quarterly earnings report on Tuesday, 2021-11-30. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

November 19, 2021

Gainers CASI Pharmaceuticals (NASDAQ:CASI

Via Benzinga

Mid-Afternoon Market Update: Dow Falls 200 Points; Connect Biopharma Shares Tumble ↗

November 19, 2021

Toward the end of trading Friday, the Dow traded down 0.58% to 35,664.58 while the NASDAQ rose 0.53% to 16,078.19. The S&P also rose, gaining 0.05% to 4,706.69. The U.S. has...

Via Benzinga

Topics Stocks

52 Biggest Movers From Friday ↗

November 22, 2021

Gainers Greenland Technologies Holding Corporation (NASDAQ: GTEC) shares surged 90.2% to close at $9.89 on Friday. Greenland Technologies highlighted the launch of second...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

November 19, 2021

Gainers SCYNEXIS (NASDAQ:SCYX) stock rose 15.69% to $7.15 during Friday's regular session. As of 12:30 EST, this security is trading at a volume of 1.2 million shares...

Via Benzinga

Mid-Day Market Update: Crude Oil Down Over 4%; UWM Holdings Shares Surge ↗

November 19, 2021

Midway through trading Friday, the Dow traded down 0.62% to 35,648.81 while the NASDAQ rose 0.53% to 16,078.23. The S&P also fell, dropping 0.01% to 4,704.35. The U.S. has the...

Via Benzinga

Topics Stocks

33 Stocks Moving In Friday's Mid-Day Session ↗

November 19, 2021

Gainers Greenland Technologies Holding Corporation (NASDAQ: GTEC) shares jumped 75.4% to $9.17. Greenland Technologies highlighted the launch of second electric industrial...

Via Benzinga

Mid-Morning Market Update: Markets Mixed; Foot Locker Profit Beats Views ↗

November 19, 2021

Following the market opening Friday, the Dow traded down 0.66% to 35,634.40 while the NASDAQ rose 0.54% to 16,079.51. The S&P also fell, dropping 0.03% to 4,703.27. The U.S....

Via Benzinga

Topics Stocks

The Daily Biotech Pulse: Connect Biopharma Sinks On Eczema Drug Readout, Enanta Pulls Plug On HBV Drug, Clinical Setback For Merck In HIV Trial ↗

November 19, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Connect Biopharma Atopic Dermatitis Treatment Aces Mid-stage Study But Lack...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

November 19, 2021

Good morning, trader! We're starting off the final day of trading this week with a look at the biggest pre-market stock movers for Friday!

Via InvestorPlace

20 Stocks Moving in Friday's Pre-Market Session ↗

November 19, 2021

Gainers Mammoth Energy Services, Inc. (NASDAQ: TUSK) rose 29.9% to $2.87 in pre-market trading after the company announced a multi-year electric vehicle charging station...

Via Benzinga

Topics Electric Vehicles

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

November 18, 2021

Gainers NeuroOne Medical Tech (NASDAQ:NMTC...

Via Benzinga

RedHill Biopharma Ltd Announces RedHill: LPI in Part A of RHB-107 P2/3 COVID Study

November 15, 2021

RedHill Biopharma Announces Last Patient Randomized in Part A of Ongoing Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients Recruitment completed for Part A of the Phase...

From RedHill Biopharma Ltd

Via AccessWire

Topics Intellectual Property Regulatory Compliance

RedHill Biopharma and South Korea's Kukbo Co. Announce a Strategic Investment of Up To $10 Million in RedHill

November 08, 2021

RedHill received the first tranche of $5 million in a private placement of restricted stock priced at $6.04 per ADS, representing a 20% premium based on the 30 trading days' volume weighted average...

From RedHill Biopharma Ltd

Via AccessWire

Topics Intellectual Property Regulatory Compliance

RedHill Biopharma Presents New Talicia(R) and Movantik(R) Data Analyses at ACG 2021

October 25, 2021

Two new analyses evaluate pharmacological and clinical advantages of Talicia® as first-line H. pylori therapy over clarithromycin-based regimens - Two new analyses of Movantik® data evaluate efficacy...

From RedHill Biopharma Ltd

Via AccessWire

Topics Intellectual Property Regulatory Compliance

Why BioNTech and RedHill Are Soaring This Week, While Novavax Is Sinking ↗

October 22, 2021

All three have COVID-19 connections.

Via The Motley Fool

52 Biggest Movers From Yesterday ↗

October 20, 2021

Gainers Xiaobai Maimai Inc. (NASDAQ: HX) shares climbed 42.6% to close at $9.51 on Tuesday. Xiaobai Maimai said Xiaobao An resigned as CEO. Kaival Brands Innovations Group...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 19, 2021

Gainers Redhill Biopharma (NASDAQ:RDHL) stock increased by 18.27% to $5.76 during Tuesday's regular session. Redhill Biopharma's stock is trading at a volume of 2....

Via Benzinga

David v Goliath in The Race to Develop an Oral Therapy for COVID-19 ↗

October 19, 2021

Photo by Towfiqu barbhuiya on Unsplash Broad agreement in the world of science can be a rarity. However, one thing that public health leaders active in the fight against COVID-19...

Via Benzinga

RedHill Biopharma Announces Insider Buying

October 18, 2021

TEL-AVIV, ISRAEL and RALEIGH, NC / ACCESSWIRE / October 18, 2021 / RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that...

From RedHill Biopharma Ltd

Via AccessWire

Topics Intellectual Property Regulatory Compliance

RedHill Biopharma Ltd Announces New U.S. Patent for RedHill's Talicia for H.pylori

October 12, 2021

RedHill Biopharma Announces New U.S. Patent Covering Talicia for H. pylori Infection Through 2034 The patent is directed to the Talicia® formulation and pharmaceutical kits for use in the treatment of...

From RedHill Biopharma Ltd

Via AccessWire

Topics Intellectual Property Regulatory Compliance

RedHill Biopharma Ltd Announces Talicia(R) added to Medi-Cal CDL

October 06, 2021

RedHill Biopharma's Talicia® added to Medi-Cal Contract Drug List with No Prior Authorization Requirements Addition of Talicia® by Medi-Cal Fee-For-Service (FFS) Contract Drug List (CDL) with no prior...

From RedHill Biopharma Ltd

Via AccessWire

Topics Intellectual Property Regulatory Compliance

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal ↗

October 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (...

Via Benzinga

16 Stocks Moving in Tuesday's Pre-Market Session ↗

October 05, 2021

Gainers Marine Petroleum Trust (NASDAQ: MARPS) rose 25.4% to $6.29 in pre-market trading after gaining 8% on Monday. Agrify Corporation. (NASDAQ: AGFY) rose 17.8% to $21.76 in...

Via Benzinga

44 Biggest Movers From Yesterday ↗

October 05, 2021

Gainers Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares climbed 101.9% to close at $31.50 on Monday after the company announced its phase 2 study of XEN1101 for the treatment of...

Via Benzinga

Why RedHill Biopharma Blasted 12% Higher Today ↗

October 04, 2021

The company's Opaganib might have a promising future, after all.

Via The Motley Fool

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.